News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,779 Results
Type
Article (4360)
Company Profile (30)
Press Release (188389)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (74392)
Career Advice (82)
Deals (12437)
Drug Delivery (10)
Drug Development (22885)
Employer Resources (9)
FDA (3982)
Job Trends (4412)
News (111533)
Policy (7588)
Tag
Academia (371)
Academic (1)
Accelerated approval (6)
Adcomms (2)
Allergies (57)
Alliances (8877)
ALS (42)
Alzheimer's disease (477)
Antibody-drug conjugate (ADC) (88)
Approvals (4203)
Artificial intelligence (95)
Autoimmune disease (52)
Automation (12)
Bankruptcy (99)
Best Places to Work (4023)
Biosimilars (39)
Biotechnology (17)
Bladder cancer (66)
Brain cancer (16)
Breast cancer (270)
Cancer (1857)
Cardiovascular disease (152)
Career advice (69)
Career pathing (5)
CAR-T (68)
CDC (3)
Cell therapy (184)
Cervical cancer (12)
Clinical research (21566)
Collaboration (405)
Company closure (1)
Compensation (366)
Complete response letters (10)
COVID-19 (551)
CRISPR (29)
C-suite (252)
Cystic fibrosis (39)
Data (2954)
Depression (55)
Diabetes (171)
Diagnostics (1907)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (43)
Drug pricing (19)
Drug shortages (2)
Duchenne muscular dystrophy (72)
Earnings (59862)
Editorial (5)
Employer branding (1)
Employer resources (7)
Events (26927)
Executive appointments (220)
FDA (5291)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (351)
Gene editing (61)
Generative AI (5)
Gene therapy (176)
GLP-1 (231)
Government (691)
Grass and pollen (1)
Guidances (337)
Healthcare (5083)
HIV (23)
Huntington's disease (5)
IgA nephropathy (32)
Immunology and inflammation (77)
Immuno-oncology (6)
Indications (30)
Infectious disease (627)
Inflammatory bowel disease (75)
Inflation Reduction Act (2)
Influenza (38)
Intellectual property (99)
Interviews (10)
IPO (7677)
IRA (4)
Job creations (610)
Job search strategy (60)
Kidney cancer (8)
Labor market (19)
Layoffs (121)
Leadership (1)
Legal (1484)
Liver cancer (27)
Longevity (1)
Lung cancer (273)
Lymphoma (173)
Machine learning (11)
Management (2)
Manufacturing (161)
MASH (90)
Medical device (4226)
Medtech (4245)
Mergers & acquisitions (5183)
Metabolic disorders (383)
Multiple sclerosis (73)
NASH (8)
Neurodegenerative disease (113)
Neuropsychiatric disorders (30)
Neuroscience (897)
NextGen: Class of 2025 (1235)
Non-profit (669)
Now hiring (6)
Obesity (109)
Opinion (24)
Ovarian cancer (70)
Pain (63)
Pancreatic cancer (85)
Parkinson's disease (93)
Partnered (3)
Patents (182)
Patient recruitment (178)
Peanut (26)
People (9503)
Pharmaceutical (6)
Pharmacy benefit managers (3)
Phase I (5880)
Phase II (9130)
Phase III (8348)
Pipeline (2518)
Policy (20)
Postmarket research (699)
Preclinical (1962)
Press Release (21)
Prostate cancer (87)
Psychedelics (1)
Radiopharmaceuticals (63)
Rare diseases (230)
Real estate (827)
Recruiting (5)
Regulatory (6810)
Reports (12)
Research institute (316)
Resumes & cover letters (8)
Rett syndrome (16)
RNA editing (2)
RSV (25)
Schizophrenia (63)
Series A (41)
Series B (41)
Service/supplier (1)
Sickle cell disease (42)
Special edition (6)
Spinal muscular atrophy (46)
Sponsored (3)
Startups (391)
Stomach cancer (4)
Supply chain (15)
Tariffs (5)
The Weekly (3)
Vaccines (242)
Venture capital (12)
Weight loss (71)
Women's health (27)
Worklife (3)
Date
Today (3)
Last 7 days (179)
Last 30 days (1120)
Last 365 days (14759)
2025 (14507)
2024 (12434)
2023 (14249)
2022 (15023)
2021 (15442)
2020 (14629)
2019 (11549)
2018 (8555)
2017 (9850)
2016 (7839)
2015 (9553)
2014 (7174)
2013 (5389)
2012 (5767)
2011 (6151)
2010 (5754)
Location
Africa (104)
Alabama (39)
Arizona (83)
Arkansas (2)
Asia (10868)
Australia (1180)
California (4509)
Canada (1163)
China (301)
Colorado (201)
Connecticut (210)
Delaware (136)
Europe (25178)
Florida (698)
Georgia (182)
Idaho (14)
Illinois (241)
India (14)
Indiana (315)
Iowa (10)
Japan (179)
Kansas (37)
Kentucky (11)
Louisiana (9)
Maine (47)
Maryland (571)
Massachusetts (3227)
Michigan (118)
Minnesota (230)
Missouri (61)
Montana (11)
Nebraska (3)
Nevada (55)
New Hampshire (24)
New Jersey (1563)
New Mexico (3)
New York (1272)
North Carolina (570)
North Dakota (1)
Northern California (2228)
Ohio (90)
Oregon (8)
Pennsylvania (962)
Puerto Rico (7)
Rhode Island (10)
South America (198)
South Carolina (31)
Southern California (1855)
Tennessee (61)
Texas (844)
United States (16581)
Utah (129)
Virginia (99)
Washington D.C. (22)
Washington State (361)
Wisconsin (15)
Wyoming (1)
192,779 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
December 12, 2025
·
5 min read
Press Releases
Compounding Pharmacy Market Size Worth USD 31.77 Bn by 2034 Personalized Medicine Demand Accelerates
December 9, 2025
·
1 min read
Press Releases
Corbus Pharmaceuticals Announces Pricing of Public Offering - October 31, 2025
October 31, 2025
·
4 min read
Press Releases
Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 10, 2025
·
5 min read
Press Releases
Infectious Disease In Vitro Diagnostics Market Set to Reach USD 31.48 Billion by 2034
November 10, 2025
·
1 min read
Press Releases
Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
December 8, 2025
·
15 min read
Press Releases
Cell And Gene Therapy Clinical Trials Market Accelerates from USD 12.47 Billion in 2025 to USD 45.31 Billion by 2034
December 3, 2025
·
1 min read
Press Releases
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose
September 3, 2025
·
10 min read
Press Releases
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 31, 2025
November 2, 2025
·
5 min read
Press Releases
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 31, 2025
November 2, 2025
·
1 min read
1 of 19,278
Next
